| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |